Results 41 to 50 of about 10,731 (180)

Inflammatory Duodenal Polyposis Associated with Primary Immunodeficiency Disease: A Novel Case Report

open access: yesCase Reports in Medicine, 2017
Agammaglobulinemia is a rare form of B-cell primary immunodeficiency disease characterized by reduced levels of IgG, IgA, or IgM and recurrent bacterial infections. Agammaglobulinemia is most commonly associated with diffuse nodular lymphoid hyperplasia.
Irfan Ali Shera   +2 more
doaj   +1 more source

Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel

open access: yesFrontiers in Immunology, 2021
In the last few months the world has witnessed a global pandemic due to severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection causing coronavirus disease 2019 (COVID-19).
Nufar Marcus   +55 more
doaj   +1 more source

A Case of Good’s Syndrome Accompanied by Agammaglobulinemia and Diarrhea

open access: yesJournal of Hospital General Medicine, 2023
A 60-year-old woman with diarrhea was referred to our hospital due to low values for serum total protein, liver dysfunction with elevated biliary enzymes, and abnormal shadows on chest X- ray from a health examination.
Yuichiro Haba   +2 more
doaj   +1 more source

Hematopoietic Stem Cell Transplantation in an Infant with Immunodeficiency, Centromeric Instability, and Facial Anomaly Syndrome

open access: yesFrontiers in Immunology, 2017
Immunodeficiency, centromeric instability, and facial anomaly (ICF) syndrome is a rare autosomal recessive genetic condition with severe immunodeficiency, which leads to lethal infections if not recognized and treated in early childhood.
Katharina L. Gössling   +10 more
doaj   +1 more source

The quality of life of children and adolescents with X-linked agammaglobulinemia

open access: yes, 2009
The health-related quality of life in X-linked agammaglobulinemia was investigated in 25 children and adolescents patients through the Italian version of Pediatric Quality of Life Inventory 4.0 Generic Core Scale for patients aged less then 18 years ...
Franco, Locatelli
core   +4 more sources

Estado nutricional de pacientes pediátricos con deficiencia predominantemente de anticuerpos

open access: yesBiomédica: revista del Instituto Nacional de Salud
Introducción. La deficiencia predominantemente de anticuerpos es el grupo de errores inmunólogicos innatos más frecuente, sin embargo, hay poca información sobre el estado nutricional de los pacientes afectados. Objetivo.
Lina M. Castaño-Jaramillo   +2 more
doaj   +1 more source

Clinical case of primary immunodeficiency: X-linked agammaglobulinemia

open access: yesМедицинская иммунология, 2020
Aclinical case ofprimary immunodeficiency state (PIDS) is described: X-linked agammaglobulinemia in the boy of 8 years old. The results of molecular genetic studies: gene btk (ex 1-19) genome version GRCh38.p5, transcript version ENST00000308731 single ...
E. V. Kuvschinova   +4 more
doaj   +1 more source

Genetic Variation in Bruton Tyrosine Kinase

open access: yes, 2015
X-linked agammaglobulinemia (XLA) is a hereditary immunodeficiency caused by variations in the gene encoding for Bruton's tyrosine kinase (BTK). Patients with XLA have decreased numbers of mature B cells, lack all immunoglobulin isotypes, and therefore ...
Schaafsma, Gerard C. P.,   +2 more
core   +1 more source

Atypical X-linked agammaglobulinemia - reply

open access: yes, 1994
To the Editor: The letter of Kornfeld et al. raises two separate questions: Do some patients with mild hypogammaglobulinemia have defects in the same gene as patients with typical X-linked agammaglobulinemia?
Parolini, Ornella
core   +1 more source

Update on Non‐Biological and RNA‐Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper

open access: yesAllergy, Volume 81, Issue 9, Page 3039-3070, September 2026.
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
Franziska Roth‐Walter   +20 more
wiley   +1 more source

Home - About - Disclaimer - Privacy